AbCellera Biologics Inc. (ABCL) Earnings
NASDAQ·Healthcare·Biotechnology
$5.74
+12.77%
Mkt Cap $1.60B
EPS — Estimate vs Actual
Mkt Cap
$1.60B
P/E
—
Fwd P/E
—
P/S
20.20
Rev TTM
—
EPS TTM
-$0.48
NASDAQ·Healthcare·Biotechnology
$5.74
+12.77%
Mkt Cap $1.60B
Mkt Cap
$1.60B
P/E
—
Fwd P/E
—
P/S
20.20
Rev TTM
—
EPS TTM
-$0.48